MAS
54
-5
MDLZ
85
2
BAX
48
-2
CHK
41
7
CME
61
-4
PEP
63
6
HPE
14
2
AES
55
15
HRB
70
2
VMC
68
-3
STI
46
40
VLO
33
-3
WRK
59
3
ZION
55
2
XRAY
37
2
EMN
72
-3
BA
36
-2
TEL
71
-6
TROW
51
-3
PEG
48
2
MAS
54
-5
MDLZ
85
2
BAX
48
-2
CHK
41
7
CME
61
-4
PEP
63
6
HPE
14
2
AES
55
15
HRB
70
2
VMC
68
-3
STI
46
40
VLO
33
-3
WRK
59
3
ZION
55
2
XRAY
37
2
EMN
72
-3
BA
36
-2
TEL
71
-6
TROW
51
-3
PEG
48
2
Financhill
Back

ProPhase Labs Stock Predictions

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.
Sell
40

PRPH
ProPhase Labs

Last Price:
4.99
Seasonality Move:
6.82%

7 Day Trial

ALL ACCESS PASS

$ 7

9,530x the last time this happened

Here's what our expert says you should buy before April 14.

ProPhase Labs Stock Forecast

  • Over the next 52 weeks, ProPhase Labs has on average historically risen by 82.8% based on the past 29 years of stock performance.
  • ProPhase Labs has risen higher in 16 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.17%
  • Is ProPhase Labs Stock Undervalued?
    The current ProPhase Labs [PRPH] share price is $5.06. The Score for PRPH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will ProPhase Labs Stock Go Up Next Year?

  • Over the next 52 weeks, ProPhase Labs has on average historically risen by 82.8% based on the past 29 years of stock performance.

ProPhase Labs Stock Rating

Sell
40
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs overpriced?

  • ProPhase Labs has risen higher in 16 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.17%

ProPhase Labs Stock Price History

Is PRPH stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
prophaselabs.com

52-Week Data

52-Week High:
9.94
52-Week Low:
4.05

Prediction Charts

Market Cap:
91.31M
Price in USD:
5.06
Volume:
15.55K
Beta:
0.56

Technical Analysis

SMA50:
5.52
SMA100:
5.20
SMA200:
5.20
52-Wk Change:
-35.38%

Stock Predictions

  • Is ProPhase Labs stock public?
    Yes, ProPhase Labs is a publicly traded company.
  • What is the ProPhase Labs stock quote today?
    The ProPhase Labs stock price is 5.06 USD today.
  • How to buy ProPhase Labs stock online?
    You can buy ProPhase Labs shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-5 6.67 6.83 6.92 6.67
Apr-8 6.88 6.69 6.88 6.50
Apr-9 6.61 6.10 6.64 6.06
Apr-10 6.04 6.22 6.22 6.01
Apr-11 6.60 6.39 6.70 6.18
Apr-12 6.58 6.50 6.64 6.29
Apr-15 6.63 6.13 6.77 6.12
Apr-16 6.54 7.36 7.48 6.27
Apr-17 7.47 6.22 7.47 6.05
Apr-18 6.32 5.44 6.32 5.33
Apr-19 5.31 5.19 5.31 5.05
Apr-22 5.17 4.90 5.17 4.90
Apr-23 4.89 5.20 5.39 4.89
Apr-24 5.17 5.06 5.46 5.05

ProPhase Labs Earnings

ProPhase Labs Earnings Report: Per Share ProPhase Labs Earnings Q1 Q2 Q3 and Q4 last year and next year.

ProPhase Labs Forecast Revenue Growth

ProPhase Labs Stock Analysis: Historical quarterly revenues per share for ProPhase Labs and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.09 per share, and an increase next year of $1.31 per share.

* ProPhase Labs stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.